|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-11-14
|
|
pubmed:abstractText |
CA (cancer antigen) 125 is a serologic marker used in the monitoring of ovarian cancer. Elevated levels are also reported in cirrhosis. We evaluated the range of serum CA 125 levels seen before and after liver transplantation, and examined possible factors associated with CA 125 elevation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1519-22
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11707739-Ascites,
pubmed-meshheading:11707739-Biological Markers,
pubmed-meshheading:11707739-CA-125 Antigen,
pubmed-meshheading:11707739-Female,
pubmed-meshheading:11707739-Humans,
pubmed-meshheading:11707739-Liver Cirrhosis,
pubmed-meshheading:11707739-Liver Neoplasms,
pubmed-meshheading:11707739-Liver Transplantation,
pubmed-meshheading:11707739-Male,
pubmed-meshheading:11707739-Prospective Studies,
pubmed-meshheading:11707739-Reference Values,
pubmed-meshheading:11707739-Severity of Illness Index
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates.
|
|
pubmed:affiliation |
Division of Gastroenterology, Department of Medicine, Royal Victoria Hospital, Montréal, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
